Osteoporosis International

, Volume 14, Supplement 5, pp 22–28 | Cite as

Methodological considerations in measurement of bone mineral content

  • Georges Boivin
  • Pierre J. Meunier
Original Article


The strength of bones depends on bone matrix volume, bone microarchitecture, and on the degree of mineralization of bone (DMB), and we have recently shown in patients with osteoporosis treated with alendronate that fracture risk and bone mineralization density (BMD) were changed without modifications of bone matrix volume or bone microarchitecture [1]. Thus, DMB must not be forgotten among the factors determining the mechanical competence of bone.

How to measure qualitative and quantitative differences in the mineral content of bone samples?

Bone mineral content depends on BMD and bone matrix volume. BMD can be quantified by noninvasive methods allowing for a global evaluation of mineral substance of the bone as an organ [dual x-ray absorptiometry (DXA), tomodensitometry, quantitative ultrasound]. Conversely, invasive methods quantify the mineral substance of the bone tissue alone. The 2 methods provide very different information; however, only the latter method will be...


Bone Mineralization Density Alendronate Raloxifene Teriparatide Strontium Ranelate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors express their gratitude to Arthur Santora and John Yates (Merck Research Laboratories, Rahway, NJ) for their constant support. The collaboration of Paul Lips (Amsterdam, The Netherlands), Susan Ott (Seattle, WA), Kristine Harper (Eli Lilly and Company, Indianapolis, IN), Isabelle Tupinon-Mathieu (Institut de Recherches Internationales Servier, Courbevoie, France) is acknowledged. The expert technical assistance of Delphine Farlay, Catherine Simi, and Annie Buffet (INSERM Unité 403, Faculté de Médecine R. Laennec, Lyon, France) is also gratefully acknowledged.


  1. 1.
    Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ (2000) Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687–694Google Scholar
  2. 2.
    Arnold JS, Bartley MH, Tont SA, Jenkins DP (1966) Skeletal changes in aging and disease. Clin Orthop 49:17–38PubMedGoogle Scholar
  3. 3.
    Boivin G, Baud C (1984) Microradiographic methods for calcified tissues. In: Dickson G (ed) Methods of calcified tissue preparation. Elsevier, Amsterdam, pp 391–411Google Scholar
  4. 4.
    Meunier PJ, Boivin G (1997) Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications. Bone 21:373–377CrossRefPubMedGoogle Scholar
  5. 5.
    Boivin G, Meunier P (2002) The degree of mineralization of bone tissue measured by computerized quantitative contact microadiography. Calcif Tissue Int 70:503–511CrossRefPubMedGoogle Scholar
  6. 6.
    Reid SA, Boyde A (1987) Changes in the mineral density distribution in human bone with age: image analysis using backscattered electrons in the SEM. J Bone Miner Res 2:13–22PubMedGoogle Scholar
  7. 7.
    Skedros JG, Bloebaum RD, Bachus KN, Boyce TM (1993) The meaning of gray levels in backscattered electron images of bone. J Biomed Mater Res 27:47–56PubMedGoogle Scholar
  8. 8.
    Skedros JG, Bloebaum RD, Bachus KN, Boyce TM, Constantz B (1993) Influence of mineral content and composition on gray levels in backscattered electron images of bone. J Biomed Mater Res 27:57–64PubMedGoogle Scholar
  9. 9.
    Boyde A, Jones S, Aerssens J, Dequeker J (1995) Mineral density quantitation of the human cortical iliac crest by backscattered electron image analysis: variations with age, sex and degree of osteoarthritis. Bone 16:619–627CrossRefPubMedGoogle Scholar
  10. 10.
    Roschger P, Plenk H, Klaushofer K, Eschberger J (1995) A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K-alpha-line intensitites. Scanning Microsc 9:75–88PubMedGoogle Scholar
  11. 11.
    Roschger P, Fratzl P, Eschberger J, Klaushofer K (1998) Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23:319–326CrossRefPubMedGoogle Scholar
  12. 12.
    Bloebaum R, Skedros J, Vajda E, Bachus K, Constantz B (1997) Determining mineral content variations in bone using backscattered electron imaging. Bone 20:485–490CrossRefPubMedGoogle Scholar
  13. 13.
    Nuzzo S, Peyrin F, Cloetens P, Bachurel J, Boivin G (2002) Quantification of the degree of mineralization of bone in three dimension using synchrotron radiation microtemography. Med Phys 29:2672–2681Google Scholar
  14. 14.
    Fratzl P, Groschner M, Vogl G, et al (1992) Mineral crystals in calcified tissues: a comparative study by SAXS. J Bone Miner Res 7:329–334PubMedGoogle Scholar
  15. 15.
    Fratzl P, Schreiber S, Klaushofer K (1996) Bone mineralization as studied by small-angle x-ray scattering. Connect Tissue Res 34:247–254PubMedGoogle Scholar
  16. 16.
    Paschalis EP, Betts F, DiCarlo E, Mendelsohn R, Boskey AL (1997) FTIR microspectroscopic analysis of normal human cortical and trabecular bone. Calcif Tissue Int 61:480–486CrossRefPubMedGoogle Scholar
  17. 17.
    Camacho N, Rinnerthaler S, Paschalis E, et al (1999) Complementary information on bone ultrastruture from scanning small angle x-ray scattering and Fourier-transform infrared microspectroscopy. Bone 25:287–293CrossRefPubMedGoogle Scholar
  18. 18.
    Glimcher M (1997) The nature of the mineral phase in bone. In: Avioli LV, Krane SM (eds) Metabolic bone disease. Academic Press, San Diego, pp 23–50Google Scholar
  19. 19.
    Boivin G, Meunier P (2002) Effects of bisphosphonates on matrix mineralization. J Musculoskel Neuron Interact 2:538–543Google Scholar
  20. 20.
    Roschger P, Grabner B, Messmer P, et al (2001) Influence of intermittent PTH treatment on mineral distribution in the human ilium: a pair biopsy study before and after treatment. J Bone Min Res 17 (Suppl 1):S179Google Scholar
  21. 21.
    Roschger P, Rinnerthaler S, Yates J, et al (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29:185–191CrossRefPubMedGoogle Scholar
  22. 22.
    Nuzzo S, Lafage-Proust M, Martin-Badosa E, et al (2002) Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res 17:1372–1382PubMedGoogle Scholar
  23. 23.
    Ott S, Oleksik A, Lu Y, Harper K, Lips P (2002) Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women. J Bone Miner Res 17:341–348PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  • Georges Boivin
  • Pierre J. Meunier

There are no affiliations available

Personalised recommendations